EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature review

Chang Yue Chui iD, Dirk Jan A R Moes, Stijn L W Koolen, Jesse J Swen iD, Hans Gelderblom

British Journal of Clinical Pharmacology · 2023

DOI: 10.1111/bcp.15833 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Clinical Pharmacology, 2023. Verfasst von Chang Yue Chui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Irinotecan, Renal Insufficiency, Chronic, Camptothecin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

There are limited pharmacokinetic data on the use of irinotecan in patients with reduced glomerular filtration rate (GFR) and no haemodialysis. In this case report, we present 2 cases and review the current literature.

Methods

The dose of irinotecan in both patients was reduced pre‐emptively due to reduced GFR. The first patient had her irinotecan dose reduced to 50%, but was nevertheless admitted to hospital because of irinotecan‐induced toxicity, including gastrointestinal toxicity and neutropenic fever. The dose was reduced further to 40% for the second cycle; however, the patient was again admitted to the hospital, and irinotecan was stopped indefinitely. The second patient also had his irinotecan dose reduced to 50% and was admitted to the emergency department for gastrointestinal toxicity after the first cycle. However, irinotecan could be administered in the same dose in later cycles.

Results

The area under the curve to infinity of irinotecan and SN‐38 in the first patient were comparable to those of an individual receiving 100% dose intensity. The area under the curve to infinity of irinotecan and SN‐38 in patient 2 in both cycles were slightly less than reference values. Furthermore, clearance values of irinotecan and SN‐38 in our patients were comparable to those without renal impairment.

Conclusion

Our case report suggests that reduced GFR may not significantly affect the clearance of irinotecan and SN‐38, but can still result in clinical toxicity. Reduced initial dosing seems indicated in this patient population. Further research is needed to fully understand the relationship between reduced GFR, pharmacokinetics, and toxicity of irinotecan and SN‐38.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IrinotecanRenal Insufficiency, ChronicCamptothecinHumansFemaleGlomerular Filtration RateMiddle AgedMaleAgedTopoisomerase I Inhibitors

Stichwörter der Autor:innen

SN-38irinotecanpharmacokineticsrenal insufficiency

Substanzen

IrinotecanTopoisomerase I InhibitorsCamptothecin

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Clinical Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands.
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Chang Yue Chui, Jesse J Swen

Zitieren

APA

Chui, C. Y., Moes, D. J. A. R., Koolen, S. L. W., Swen, J. J., & Gelderblom, H. (2023). Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature review. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15833

Vancouver

Chui CY, Moes DJAR, Koolen SLW, Swen JJ, Gelderblom H. Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature review. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15833

BibTeX
@article{Chui2023,
  author = {Chui, Chang Yue and Moes, Dirk Jan A R and Koolen, Stijn L W and Swen, Jesse J and Gelderblom, Hans},
  title = {Pharmacokinetic profile of irinotecan in patients with chronic kidney disease: Two cases and literature review},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1111/bcp.15833}
}
Kostenlos starten →